From: Gene expression and adaptive noncoding changes during human evolution
Collection # | sets | r_r | p(r_r) | q(r_r) |
---|---|---|---|---|
C3:TFT (transcription factor targets) | 472 | 0.35 | < 0.0001 | < 0.0005 |
C2:CGP (chemical and genetic perturbations) | 645 | 0.28 | < 0.0001 | < 0.0005 |
C7:All (immunologic signatures) | 1723 | 0.14 | < 0.0001 | < 0.0005 |
C4:CGN (cancer gene neighborhoods) | 88 | 0.5 | 0.012 | 0.045 |
C6:All (oncogenic signatures) | 109 | 0.22 | 0.019 | 0.057 |
C4:CM (cancer modules) | 87 | 0.29 | 0.036 | 0.09 |
C5:CC (GO cellular components) | 37 | 0.33 | 0.14 | 0.27 |
C3:MIR (microRNA targets) | 109 | 0.11 | 0.14 | 0.27 |
C1:All (positional gene sets) | 9 | 0.17 | 0.34 | 0.53 |
H:All (hallmark gene sets) | 25 | 0.089 | 0.35 | 0.53 |
C2:CP:Reactome (Reactome gene sets) | 39 | 0.058 | 0.4 | 0.55 |
C2:CP:KEGG (KEGG gene sets) | 11 | −0.17 | 0.7 | 0.88 |
C2:CP:Other (other canonical pathways) | 6 | −0.49 | 0.8 | 0.93 |
C5:BP (GO biological processes) | 123 | −0.28 | 0.95 | 0.96 |
C5:MF (GO molecular functions) | 44 | −0.41 | 0.96 | 0.96 |